|
BBLGW Bone Biologics 1419554 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-773,702.00 |
| Balance Sheet |
|
Current Assets
|
$4,436,668.00 |
|
Assets
|
$4,436,668.00 |
|
Current Liabilities
|
$512,018.00 |
|
Liabilities
|
$512,018.00 |
|
Equity
|
$3,924,650.00 |
|
Shares Out
|
1810380.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,322,722.00 |
| Market Analysis |
Market Cap
|
$14,917,531.20 |
|
Price
|
$8.24 |
|
BVPS
|
2.17 |
|
PB
|
3.80 |
|
EPS
|
-0.43 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:18 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BBLGW documents filed with the SEC.
BBLGW Filings
Clear
